Novo Nordisk A/S NOVA.F Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S NOVA.F Financial and Trading Overview
| Novo Nordisk A/S stock price | 117.5 EUR |
| Previous Close | 88.6 EUR |
| Open | 88.4 EUR |
| Bid | 0 EUR x 100000 |
| Ask | 0 EUR x 100000 |
| Day's Range | 88.4 - 89.6 EUR |
| 52 Week Range | 60 - 98.8 EUR |
| Volume | 208 EUR |
| Avg. Volume | 598 EUR |
| Market Cap | 396.98B EUR |
| Beta (5Y Monthly) | 0.194 |
| PE Ratio (TTM) | 39.466667 |
| EPS (TTM) | 2.49 EUR |
| Forward Dividend & Yield | 0.95 (1.06%) |
| Ex-Dividend Date | August 18, 2023 |
| 1y Target Est | 116.88 EUR |
NOVA.F Valuation Measures
| Enterprise Value | 376.49B EUR |
| Trailing P/E | 39.466667 |
| Forward P/E | 25.889214 |
| PEG Ratio (5 yr expected) | 145.66 |
| Price/Sales (ttm) | 1.8508232 |
| Price/Book (mrq) | 4.2751913 |
| Enterprise Value/Revenue | 1.755 |
| Enterprise Value/EBITDA | 3.761 |
Trading Information
Novo Nordisk A/S Stock Price History
| Beta (5Y Monthly) | 0.194 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 98.8 EUR |
| 52 Week Low | 60 EUR |
| 50-Day Moving Average | 92.15 EUR |
| 200-Day Moving Average | 80.94 EUR |
NOVA.F Share Statistics
| Avg. Volume (3 month) | 598 EUR |
| Avg. Daily Volume (10-Days) | 794 EUR |
| Shares Outstanding | 4.46B |
| Float | 3.31B |
| Short Ratio | N/A |
| % Held by Insiders | 0.0050% |
| % Held by Institutions | 8.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 7.075 |
| Trailing Annual Dividend Yield | 7.98% |
| 5 Year Average Dividend Yield | 174.00% |
| Payout Ratio | 0.41990003 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.11% |
| Operating Margin (ttm) | 45.82% |
| Gross Margin | 84.14% |
| EBITDA Margin | 46.67% |
Management Effectiveness
| Return on Assets (ttm) | 21.57% |
| Return on Equity (ttm) | 88.77% |
Income Statement
| Revenue (ttm) | 214.49B EUR |
| Revenue Per Share (ttm) | 47.73 EUR |
| Quarterly Revenue Growth (yoy) | 28.89% |
| Gross Profit (ttm) | 148.51B EUR |
| EBITDA | 100.11B EUR |
| Net Income Avi to Common (ttm) | 75.31B EUR |
| Diluted EPS (ttm) | 2.25 |
| Quarterly Earnings Growth (yoy) | 56.00% |
Balance Sheet
| Total Cash (mrq) | 47.59B EUR |
| Total Cash Per Share (mrq) | 10.63 EUR |
| Total Debt (mrq) | 26.54B EUR |
| Total Debt/Equity (mrq) | 28.54 EUR |
| Current Ratio (mrq) | 0.824 |
| Book Value Per Share (mrq) | 20.771 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 106.46B EUR |
| Levered Free Cash Flow (ttm) | 63.8B EUR |
Profile of Novo Nordisk A/S
| Country | Germany |
| State | N/A |
| City | Bagsvaerd |
| Address | Novo Alle 1 |
| ZIP | 2880 |
| Phone | 45 44 44 88 88 |
| Website | https://www.novonordisk.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 61412 |
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current NOVA.F stock price?
Novo Nordisk A/S NOVA.F stock price today per share is 117.5 EUR.
How to purchase Novo Nordisk A/S stock?
You can buy NOVA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is NOVA.F.
Which industry does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S industry is Biotechnology.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 4.48B.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 47.18875500 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 2.49 EUR over the trailing 12 months.
Which sector does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S sector is Healthcare.